U.S. Tobacco Stock News

NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab MSP AI Push Targets Enterprise DevSecOps Adoption Risks And Rewards

GitLab (NasdaqGS:GTLB) has launched an expanded Managed Service Provider Partner Program that integrates agentic AI across the software development lifecycle. The new program is designed to help MSPs deliver AI driven DevSecOps services while addressing data sovereignty and compliance needs in different regions. This move broadens GitLab’s partner ecosystem and focuses on enterprise demand for AI based software lifecycle management. For you as an investor, this development sits at the...
NasdaqCM:SPT
NasdaqCM:SPTSoftware

Sprout Social (SPT) Is Up 9.1% After Mixed Q4 Results and New 2026 Outlook – What’s Changed

Sprout Social recently reported fourth-quarter 2025 revenue of US$120.89 million and a net loss of US$10.74 million, alongside filing a US$23.19 million shelf registration for 3,573,414 Class A shares tied to its employee stock ownership plans. The combination of improving loss per share, new 2026 revenue guidance, and potential employee share issuance offers fresh insight into how Sprout Social is funding growth and rewarding staff while remaining unprofitable. Against this backdrop of...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy PrintKK Partnership Puts AI And Automation At Center Stage

PrintKK has launched a global, integrated print on demand solution for Etsy sellers, adding automation and AI powered design tools. The integration gives sellers access to a wide range of customizable products and automated fulfillment aimed at international buyers. This development introduces new ways for Etsy merchants to test products without holding inventory and could influence the variety of items available on the marketplace. Etsy, listed on the NYSE under ticker NYSE:ETSY, is...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Monster Beverage (MNST) Is Down 11.5% After Earnings Beat And New Regional CEOs Announced – Has The Bull Case Changed?

In late February 2026, Monster Beverage Corporation reported fourth-quarter 2025 results showing sales of US$2,131.05 million and net income of US$449.19 million, alongside leadership changes that installed new regional CEOs for the Americas and EMEA & OSP and a new Chief Strategy Officer. Full-year 2025 sales of US$8,294.34 million and net income of US$1,905.43 million, coupled with earnings that outpaced analyst expectations and strong international contributions, have reinforced Monster’s...
NYSE:ALL
NYSE:ALLInsurance

Allstate Data Privacy Lawsuit Puts Telematics Strategy And Returns Under Review

A U.S. District Judge has allowed a class action lawsuit against Allstate to proceed. The suit alleges Allstate collected and used driver behavior data from cellphones without proper consent. Plaintiffs claim the company adjusted premiums, denied coverage, and shared data with other insurers. Alleged violations include the Federal Wiretap Act and Fair Credit Reporting Act. For investors watching Allstate (NYSE:ALL), this case puts data practices and customer trust under a spotlight. The...
NYSE:GLOB
NYSE:GLOBIT

Why Globant (GLOB) Is Up 13.5% After AI Pods-Focused 2026 Outlook And Heavy Buybacks

Globant S.A. recently reported fourth-quarter 2025 results showing sales of US$612.47 million and net income of US$41.56 million, and has been actively repurchasing shares, buying back 820,045 shares for US$49.98 million under its latest program. Alongside these results, the company outlined an AI-focused growth plan centered on its AI Pods subscription model and record bookings, while issuing 2026 revenue guidance that points to modest top-line changes but increased emphasis on recurring,...
NYSE:ETN
NYSE:ETNElectrical

Eaton Taps Insider CFO As Mobility Spinoff And Ultra PCS Deal Advance

Eaton (NYSE:ETN) has appointed David Foster as Chief Financial Officer, marking a key leadership change. The move comes as Eaton prepares a planned spin off of its Mobility business. Foster will also oversee the integration of Ultra PCS Limited into Eaton's operations. Eaton enters this CFO transition with its shares at $354.79 and a 1 year return of 29.5%. Over 3 years the stock has delivered a very large gain, and over 5 years it is up 177.3%. Recent shorter term moves have been softer,...
NasdaqGS:TBLA
NasdaqGS:TBLAInteractive Media and Services

Taboola.com (TBLA) Valuation Check After Swing To Profit And New Revenue Guidance

Why Taboola.com (TBLA) is back on investor radar Taboola.com (NasdaqGS:TBLA) is in focus after reporting fourth quarter and full year 2025 results that shifted from a prior year net loss to net income, along with new 2026 revenue guidance. See our latest analysis for Taboola.com. The earnings release and fresh 2026 guidance have put Taboola.com back in focus, with a 1 day share price return of 6.92% and 7 day share price return of 11.11% contrasting with a weaker year to date share price...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Why Precigen (PGEN) Is Down 11.5% After Mixed Quarterly Results And What's Next

In the past few days, Precigen reported quarterly results that surprised on revenue but fell short on earnings per share expectations, drawing fresh attention to its gene and cell therapy pipeline. An interesting angle is that analysts remain focused on anticipated revenue expansion despite the earnings miss, suggesting the top-line trajectory is central to how the company is being evaluated. We’ll now examine how this revenue surprise alongside an earnings miss may reshape Precigen’s...
NYSE:AFL
NYSE:AFLInsurance

Is Aflac (AFL) Attractively Priced After Strong Multi‑Year Share Price Gains?

If you are wondering whether Aflac's current share price gives you good value or not, you are in the right place for a clear look at what you might be paying for. Aflac's stock recently closed at US$111.04, with returns of 0.7% year to date and 5.1% over the past year, following a 144.1% return over five years and a very large 3 year gain of 82.9%. Recent coverage around Aflac has focused on its position as a major US insurance name and how investors view insurers in the current market,...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton Expands Affordable Sun Belt Communities As Valuation Risks Linger

D.R. Horton (NYSE:DHI) recently acquired 92 lots in the Indian Springs community in Texas as part of its affordable housing expansion. The company also launched Driftwood Bay, a new home community in Southwest Florida, focused on affordable and modern housing options. D.R. Horton, one of the largest homebuilders in the United States, is leaning further into affordable housing with new projects in Texas and Florida. The purchase of 92 lots in Indian Springs and the launch of Driftwood Bay...
NYSE:KKR
NYSE:KKRCapital Markets

Is KKR (KKR) Pricing In Too Much Optimism After Its Recent Share Price Slide?

If you are wondering whether KKR's current share price reflects its true worth, you are not alone. The stock's recent moves have raised fresh questions about value and risk. KKR closed at US$95.59, with returns of 2.1% over the past week, a 7.4% decline over 30 days, a 25.8% decline year to date, and a 17.2% decline over 1 year, while the 3 year and 5 year returns sit at 79.5% and 107.0% respectively. Recent headlines around KKR have focused on its role as a major global investment firm and...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Is It Time To Reassess Super Micro Computer (SMCI) After AI Server Surge And Pullback

If you are wondering whether Super Micro Computer's share price still reflects its true worth, you are not alone. The stock has been closely watched by investors focused on value. The shares last closed at US$32.24, with returns of a 0.5% decline over 7 days, a 4.5% decline over 30 days, a 4.1% gain year to date and a 15.7% decline over the past year, while the three year return is 247.6% and the five year return is roughly 8x. Recent news coverage has centered on Super Micro Computer's role...
NYSE:LC
NYSE:LCConsumer Finance

LendingClub’s Banking Shift Puts Profitability And Valuation In Focus

LendingClub (NYSE:LC) has shifted from a marketplace only platform to a fully regulated US bank. The company has reported a period of strong revenue growth alongside a move from losses to profitability. This change alters how LendingClub funds loans and manages risk on its own balance sheet. LendingClub now trades at $15.14, with the stock up 32.8% over the past year and 83.3% over three years, despite a 20.8% decline year to date. That mix of gains and recent pullback gives investors a...
NYSE:LEN
NYSE:LENConsumer Durables

Is Lennar (LEN) Pricing Fair After Recent Share Price Weakness?

If you are wondering whether Lennar's share price reflects its real worth, this article will walk through what the current market price might be implying about the company's value. Lennar's stock closed at US$104.30, with returns of a 6.9% decline over 7 days, a 7.3% decline over 30 days, roughly flat at 0.1% year to date, and a 15.8% decline over 1 year, while the 3 year and 5 year returns sit at 19.6% and 33.5% respectively. Recent share price moves have kept Lennar on the radar for...
NYSE:ACA
NYSE:ACAConstruction

Arcosa Refocuses On Infrastructure As Barge Sale Reshapes Earnings Story

Arcosa (NYSE:ACA) announced the sale of its barge business and is shifting its focus toward construction materials and engineered structures. The move is aimed at concentrating resources on U.S. infrastructure and power related businesses that management views as core to the company. Arcosa, trading at $111.28 at the last close, is coming off a strong longer term stretch, with the stock up 37.0% over the past year and 87.8% over three years. The company is also ahead 76.5% over five years,...
NYSE:MUX
NYSE:MUXMetals and Mining

A Look At McEwen Mining (MUX) Valuation After CEO’s PDAC 2026 Metals Outlook

Comments from McEwen (NYSE:MUX) chair and CEO Rob McEwen at the PDAC 2026 conference have put fresh attention on mining equities, as he pointed to a potential investor shift toward metals like gold and copper. See our latest analysis for McEwen. McEwen's comments at PDAC come at a time when the share price has pulled back in the short term, with a 1 day share price return showing a 6.39% decline and a 7 day share price return showing a 14.77% decline. However, the 90 day share price return of...
NYSE:HASI
NYSE:HASIDiversified Financial

How Investors Are Reacting To HASI’s Shift From 2027 Senior Notes To Longer‑Dated Green Debt

HA Sustainable Infrastructure Capital recently redeemed all US$450,000,000 of its 8.000% senior notes due 2027, using proceeds from new 6.000% green senior unsecured notes due 2036 and 7.125% green junior subordinated notes due 2056. This refinancing not only lengthens the company’s debt maturity profile but also aligns its funding base more closely with sustainability-focused investment projects. Next, we will examine how replacing higher‑coupon 2027 senior debt with longer‑dated green...
NYSE:XPEV
NYSE:XPEVAuto

XPeng VLA 2.0 And Robotaxis Add New Layer To XPEV Story

XPeng has launched its second generation Vision Language Action smart driving system, VLA 2.0, aimed at fully autonomous driving capabilities. Volkswagen will be the first external customer for VLA 2.0, marking a new technology partnership between the two automakers. XPeng plans to roll out fully autonomous robotaxis powered by VLA 2.0 as part of its commercial push in AI driven mobility. XPeng, listed as NYSE:XPEV, is putting this move in front of investors at a time when its share price...
NYSE:LTH
NYSE:LTHHospitality

Life Time Group Launches US$500m Buyback As Valuation Signals Diverge

Life Time Group Holdings (NYSE:LTH) has approved a new $500 million share repurchase program. The buyback plan targets the company's common stock and is intended to support long term shareholder value. This authorization adds a fresh capital allocation lever for the fitness and lifestyle operator. Life Time Group Holdings, trading at $26.12 per share, is coming off a mixed share price run, with a 51.2% gain over three years but a 13.3% decline over the past year. In the shorter term, the...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion Pharmaceuticals (RXRX) Is Down 6.1% After Insider Sale And New ATM Equity Program - Has The Bull Case Changed?

In late February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million with a quarterly net loss of US$108.12 million, and around the same time filed a US$300 million at-the-market follow-on equity offering plus a US$68.57 million shelf registration tied to an ESOP. Shortly after these filings, Director Blake Borgeson sold 170,000 Class A shares while still retaining more than 6.25 million shares, drawing attention to insider sentiment alongside the...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Assessing Huntington Bancshares (HBAN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Signals

Huntington Bancshares at a glance Huntington Bancshares (HBAN) has drawn attention after recent share price weakness, with the stock down about 9% over the past month and modestly lower over the past 3 months. At a last close of $16.68, the regional bank carries a value score of 3 and reports annual revenue of $7,692.0 and net income of $2,087.0, both stated with positive annual growth rates. See our latest analysis for Huntington Bancshares. The recent 9.3% 30 day share price decline and...
NYSE:TRV
NYSE:TRVInsurance

Travelers Insider Sales Contrast With Strong AI Driven Underwriting Performance

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Catalyst Pharmaceuticals Record 2025 Results Highlight Rare Disease Growth Story

Catalyst Pharmaceuticals (NasdaqCM:CPRX) reported record full year and Q4 2025 results, highlighting organic growth across its portfolio. The company noted continued market uptake of its lead rare disease treatments, including AGAMREE and FIRDAPSE. Management discussed how recent alliances and product momentum position Catalyst within the rare disease treatment space. Catalyst Pharmaceuticals focuses on therapies for rare neurological and neuromuscular conditions, an area where treatment...